Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia | Zendy

Jeffrey A. Lieberman | Zendy; T. Scott Stroup | Zendy; Joseph P. McEvoy | Zendy; Marvin S. Swartz | Zendy; Robert A. Rosenheck | Zendy; Diana O. Perkins | Zendy; Richard S.E. Keefe | Zendy; Sonia M. Davis | Zendy; C.E. Davis | Zendy; Barry D. Lebowitz | Zendy; Joanne B. Severe | Zendy; John Hsiao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Author(s) -

Jeffrey A. Lieberman,

T. Scott Stroup,

Joseph P. McEvoy,

Marvin S. Swartz,

Robert A. Rosenheck,

Diana O. Perkins,

Richard S.E. Keefe,

Sonia M. Davis,

C.E. Davis,

Barry D. Lebowitz,

Joanne B. Severe,

John Hsiao

Publication year - 2005

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa051688

Subject(s) - ziprasidone , quetiapine , olanzapine , risperidone , perphenazine , medicine , discontinuation , antipsychotic , atypical antipsychotic , clozapine , schizophrenia (object oriented programming) , psychiatry , anesthesia , pharmacology

The relative effectiveness of second-generation (atypical) antipsychotic drugs as compared with that of older agents has been incompletely addressed, though newer agents are currently used far more commonly. We compared a first-generation antipsychotic, perphenazine, with several newer drugs in a double-blind study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research